Demographic Characteristics and Initial Diagnostic Staging of Patients with Bladder Cancer across Large Community Health Systems in the US
Author(s)
Lorenzo R1, Pomerantz D2, Wolf F2, Brown T2, Rioth M2, Wolfe T2, Lerman M2, Sanchez N2
1Syapse, Palm Beach Gardens, FL, USA, 2Syapse, San Francisco, CA, USA
Presentation Documents
OBJECTIVES: Community health systems (CHS) in the US play a large role in the care of patients with cancer, with over 50% of patients with cancer cared for within CHS. The profile of patients with bladder cancer seen in CHS within the US is not widely published. This analysis describes the demographic and diagnostic staging characteristics of patients with bladder cancer across a sample of CHS.
METHODS: A retrospective analysis was performed utilizing the Syapse Learning Health Network
TM (LHN), an electronic medical record (EMR) derived database that collects cancer care data from multiple care settings within CHS across 33 states, 450+ hospitals and from patients cared for by 1,900+ oncologists. Patients aged >18 yo at bladder cancer diagnosis were identified from the LHN using ICD-10 codes. Data utilized for this analysis included both structured data (EMR fields like sex and birth date) and unstructured data (e.g. physician notes) validated by Certified Tumor Registrars and descriptively summarized.RESULTS: 18,277 patients from the Syapse LHN were included in the analysis. 99% of patients were initially diagnosed with bladder cancer after January 1, 2010. Patient demographics included: median age of 73 yo at bladder cancer diagnosis; 73% male; race including 90% White, 7% Black or African American, 1% Asian; and 3% with Hispanic/Latino ethnicity. 14,872 (81%) patients had stage at diagnosis available, with stage distribution including: 0 - 44%; I - 26%; II - 15%; III - 7%; and IV - 8%.
CONCLUSIONS: As expected, a large majority of patients diagnosed with bladder cancer in CHS are men, with diagnosis at an advanced age
. A majority of patients were diagnosed with stage 0 or I disease. Additional analysis is planned to provide further insight into diagnostic and treatment patterns of patients with bladder cancer treated within these CHS.Conference/Value in Health Info
Value in Health, Volume 25, Issue 6, S1 (June 2022)
Code
RWD22
Topic
Study Approaches
Topic Subcategory
Electronic Medical & Health Records
Disease
Oncology